Results

1–8 of 8 results for ellipsoid zone

Evaluation of EZ At-Risk Burden in Automatic Detection of Hydroxychloroquine Retinopathy
Katherine E Talcott, MD
Annual Meeting Talks
2023
Use of Ellipsoid Zone Analysis As an Efficacy Endpoint in Clinical Trials for Geographic Atrophy
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2023
Protective Effects of ANX007 on Central Macular Ellipsoid Zone (EZ) and Retinal Pigment Epithelium (RPE) and Association with Visual Acuity in the Phase 2 ARCHER GA Study
Glenn J. Jaffe, MD
Annual Meeting Talks
2024
Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor-Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
John A. Wells, MD, FACS
Annual Meeting Talks
2024
Baseline Ellipsoid Zone Integrity Features as Predictors of Geographic Atrophy Growth Rate in the Phase 3 GATHER Clinical Trials
Katherine E Talcott, MD
Annual Meeting Talks
2024
Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor–Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2
John A. Wells, MD, FACS
Updates from the Field
2024
VISTA-DME Study Insights in Ellipsoid Zone Dynamics and Retinal Fluid Index
Ronald W Milam, MD
On Demand Cases, Courses, and Papers
2019
Longitudinal Ellipsoid Zone Mapping on Spectral Domain OCT in Eyes With Hydroxychloroquine Use to Evaluate for Subclinical Outer Retinal Alterations
Katherine E Talcott, MD
Annual Meeting Talks
2019